Brief: Novonesis Proposes Dividend Of DKK 4.25 Per Share For Remainder Of 2025
25/02/2026 07:21
Feb 25 (Reuters) - Novozymes A/S NSISb.CO: NOVONESIS OUTLOOK FY ADJUSTED EBITDA MARGIN 37-38% 2026 OUTLOOK: ORGANIC SALES GROWTH BETWEEN 5-7% WITH A GOOD START TO YEAR EXPECTED AGAINST A STRONG 2025 COMPARABLE PROPOSED DIVIDEND OF DKK 4.25/SHARE OUTLOOK FOR ADJUSTED EBITDA MARGIN IS BETWEEN 37-38% IN 2026 IN 2026, WE EXPECT ANOTHER GOOD YEAR, WITH GROWTH ACROSS ALL SALES AREAS AND MARGIN EXPANSION. Q4 NET REVENUE EUR 996.6 MILLION VERSUS EUR 1,019.8 MILLION SEEN IN COMPANY-PROVIDED CONSENSUS Q4 ORGANIC GROWTH 4% VERSUS 5.2% SEEN IN COMPANY-PROVIDED CONSENSUS Q4 ADJUSTED EBITDA EUR 364.6 MILLION VERSUS EUR 374.6 MILLION SEEN IN COMPANY-CONSENSUS Q4 ADJUSTED EBITDA MARGIN 36.6% VERSUS 36.7% SEEN IN IN COMPANY-CONSENSUS 2025 PAY-OUT RATIO OF 58.4% OF ADJUSTED. NET PROFIT PROPOSES DIVIDEND OF DKK4.25 PER SHARE FOR REMAINDER OF 2025, FOR TOTAL PAYOUT OF DKK 6.5 (EUR 0.87) PER SHARE Source text: ID:nGNE7GgThY Further company coverage: [NSISb.CO] (Gdansk Newsroom) ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))